In the BioHarmony Drug Report Database
Mytesi (crofelemer) is a small molecule pharmaceutical. Crofelemer was first approved as Mytesi on 2012-12-31. It is used to treat diarrhea in the USA. The pharmaceutical is active against anoctamin-1 and cystic fibrosis transmembrane conductance regulator. Mytesi’s patent is valid until 2031-10-31 (FDA).
Image (chem structure or protein)